Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

27th Psychiatric Pharmacotherapy Update 2015 • Pharmacist (CPE)


2015 Psychiatric Pharmacotherapy Update • October 22-23 • Austin

The University of Texas College of Pharmacy welcomes you to the 2015 Psychiatric Pharmacotherapy Update CE event, in Austin, Texas on October 23-24. The Psychiatric Pharmacotherapy Update traditionally provides 15 hours of CEU's on current treads in mental illness treatment for pharmacists, physicians, psychiatrists, psychologists, advance practice nurses, counselors, and social workers.

Hotel Reservations:  See Location website for more information:  https://www.utexas.edu/pharmacy/ce/conferences/psych/location.html

Date: Oct 22, 2015 07:00 AM - Oct 23, 2015 06:00 PM

Fee

$425.00

CE Hours

15.00

CE Units

1.500

Registration closes on Oct 25, 2015 12:00 AM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
 

Requirements for CE Credit

ACPE Logo

The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This two-day activity is approved for 1.5 CEUs (15 contact hours) of continuing education credit.  In order to receive 15 contact hours of CE credit, the participant must attend/participate in all sessions of the program, return their completed Record of Attendance Form at the conclusion of the program, and return to this website to complete the online evaluation.

 
MUST COMPLETE CPE EVALUATIONS BY DECEMBER 14, 2015, OR FORFIT CPE CREDIT
As of May 1, 2014, ACPE has placed a strict limit of 60 days to complete the CPE requirements for credit for all pharmacy continuing education programs.  
Pharmacists who fail to complete the requirements for credit for this program will forfit CPE credit for this activity.  
Per rule set by ACPE, The University of Texas at Austin College of Pharmacy will not be able to process credit after the 60 day deadline, and will not be able to route credits to the NABP eProfiles. 
This includes error caused by incorrect NABP#'s and/or Date of Birth on you profile. Please ensure your information is correct and up-to-date prior to completing the evaluations. 
It is up to the conference attendee to ensure their credits have been received. 
 

Please choose a Fee Type from the Drop Down Menu Below:
I am a
 

 

Registration closes on Oct 25, 2015 at 12:00 AM

Registration Closed  

Date: 10/22/15
Time: 08:00 AM - 08:15 PM
Registration Closed  

Registration Closed  

Objectives

  • Describe the pharmacology, adverse effects, drug interactions, therapeutic uses,m and dosing of selected psychiatric drugs recently marketed as well as drugs approaching the market.
  • Review pharmacology, adverse effects., drug interactions, therapeutic uses, and dosing of selected psychiatric drugs that have been released in the past five years.

Activity Number

0067-0000-15-100-L04-P
Date: 10/22/15
Time: 08:15 AM - 09:30 AM

CE Hours

1.25
Registration Closed  

Registration Closed  

Objectives

  • Define treatment resistant depression
  • Discuss trends in managing treatment resistant depression today
  • Critically review patient case studies on current approaches to patients with treatment resistant depression.

Activity Number

0067-0000-15-101-L01-P
Date: 10/22/15
Time: 09:30 AM - 10:30 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Describe empirically based treatments, including both psychotherapy and pharmacotherapy, for pediatric patients with depression.
  • Discuss consensus guidelines for medication treatment algorithms for childhood and adolescence depressive disorders. (Case studies)

Activity Number

0067-0000-15-102-L01-P
Date: 10/22/15
Time: 10:45 AM - 11:45 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Describe the impact of nutrition, exercise, sleep, hormones, substances, and lifestyle on behavior and learning.
  • Assess the risks of imbalances in biological factors related to health/wellness, behavior, and learning.
  • Recognize first-line non-drug approaches and how to improve outcomes in treatment.

Activity Number

0067-0000-15-103-L04-P
Date: 10/22/15
Time: 11:45 AM - 12:45 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Describe tips for diagnosing and treating patients with intellectual disabilities and comorbid mental illness
  • Describe empirically based treatments, including both psychotherapy and pharmacotherapy –case studies

Activity Number

0067-0000-15-104-L01-P
Date: 10/22/15
Time: 01:45 PM - 02:45 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Identify best practices and trends for use of long acting injectable in outpatient and clinical settings.
  • Discuss clinical and ethical dilemmas resulting from the use of long- acting injections.
  • Critically discuss the evidence-based management of long- acting injectables

Activity Number

0067-0000-15-105-L01-P
Date: 10/22/15
Time: 02:45 PM - 04:00 PM

CE Hours

1.25
Registration Closed  

Registration Closed  

Objectives

  • Compare and contrast use of the new FDA pregnancy and lactation labeling with the use of previously utilized systems.
  • Formulate plans for assessment and treatment of the pregnant or breastfeeding psychiatric parent.
  • Utilize psychiatric pharmacotherapy toolkit of best practices when treating pregnant and breastfeeding patients.
  • Recognize ethical dilemmas related to use of psychotropic agents during pregnancy lactation.

Activity Number

0067-0000-15-106-L01-P
Date: 10/22/15
Time: 04:15 PM - 05:30 PM

CE Hours

1.25
Registration Closed  

Registration closes on Oct 25, 2015 at 12:00 AM

Registration Closed  

Activity Number

0067-0000-15-107-L01-P
Date: 10/23/15
Time: 08:00 AM - 09:00 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Activity Number

0067-0000-15-108-L01-P
Date: 10/23/15
Time: 09:00 AM - 10:15 AM

CE Hours

1.25
Registration Closed  

Registration Closed  

Objectives

  • Define basic understanding of genetic principles applicable to the study of pharmacogenomics
  • Discuss outcomes of pharmacogenomics studies related to psychotropic agents
  • Explain applicability of pharmacogenomics to the psychiatric patient receiving psychotropic agents

Activity Number

0067-0000-15-109-L04-P
Date: 10/23/15
Time: 10:30 AM - 11:30 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Evidence for using psychotropic medications in the elderly
  • Cognitive effects of psychotropics in the elderly
  • Management of cognitive effects of psychotropic medications in the elderly

Activity Number

0067-0000-15-110-L01-P
Date: 10/23/15
Time: 11:30 AM - 12:30 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Discuss consequences of alcohol use before and during pregnancy
  • Explain the scope and problems of FASD's and the psychiatric effects of prenatal alcohol use on the developing fetus.
  • Discuss ethical dilemmas for practitioners in treatment of mother and child regarding fetal alcohol disorders.

Activity Number

0067-0000-15-111-L01-P
Date: 10/23/15
Time: 12:30 PM - 01:30 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Describe the pathophysiology and the challenges associated with diagnosis of epileptic seizures.
  • Identify new treatment options available for management of epilepsy and apply them to patient cases using evidence-based medicine.
  • Compare newer antiepileptic drugs with older agents and discuss their role in treating epilepsy
  • Explain management of epilepsy in special populations such as pregnant females, mental retardation and TBI patients

Activity Number

0067-0000-15-112-L01-P
Date: 10/23/15
Time: 01:30 PM - 02:30 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Evaluate diagnostic methods and treatment of ADHD in adults.
  • Identify the differences between stimulant and non-stimulant treatments
  • Identify the differential diagnosis of attention problems in adulthood.
  • Discuss how to use both pharmacological and psychosocial interventions in adult ADHD
  • Discuss misuse of diversion of stimulants when treating adults with ADHD.

Activity Number

0067-0000-15-113-L01-P
Date: 10/23/15
Time: 02:30 PM - 03:30 PM

CE Hours

1.00
Registration Closed